Skip to main content
Top
Published in: Inflammation 3/2017

01-06-2017 | ORIGINAL ARTICLE

IRF3 Inhibits Neutrophil Recruitment in Mice Infected with Pseudomonas aeruginosa

Authors: Zhenghao Piao, Haiying Yuan, Cuili Wang, Liyun Shi

Published in: Inflammation | Issue 3/2017

Login to get access

Abstract

Pseudomonas aeruginosa is the major cause of morbidity and mortality in patients with ventilator-associated pneumonia. Interferon regulatory factor 3 (IRF3) is a transcription factor that plays an important role in the immune response to viral infection via the IRF3/IFN-β signaling pathway. Controversial data exist regarding the role of IRF3 in immune cell recruitment during bacterial infections. IRF3 has been shown to promote neutrophil recruitment and bacterial clearance in mice infected with P. aeruginosa by inducing the production of specific chemokines and cytokines. In contrast, our study showed that IRF3 knockout (KO) mice infected with P. aeruginosa exhibited greater survival rates, demonstrated enhanced bacterial clearance, and showed significantly increased neutrophil recruitment to the lungs, when compared with the wild-type (WT) mice. The peritoneal lavage fluid collected from IRF3 KO mice 4 h after intraperitoneal injection with P. aeruginosa or 3% thioglycolate contained a significantly increased number of neutrophils. Furthermore, neutrophils from the bone marrow (BM) of IRF3 KO mice showed greater adhesiveness to the extracellular matrix when compared with those of WT mice, post-P. aeruginosa infection. In addition, IRF3 induced the expression of target genes in WT neutrophils infected with P. aeruginosa. These findings indicate that IRF3 exacerbates P. aeruginosa-induced mortality in mice by inhibiting neutrophil adhesion and recruitment to the lungs. Together, these data indicate that the inhibition of IRF3 might provide a possible mechanism for controlling P. aeruginosa infections.
Literature
1.
go back to reference Rello, J., T. Lisboa, and D. Koulenti. 2014. Respiratory infections in patients undergoing mechanical ventilation. Lancet Respir Med 2: 764–774.CrossRefPubMed Rello, J., T. Lisboa, and D. Koulenti. 2014. Respiratory infections in patients undergoing mechanical ventilation. Lancet Respir Med 2: 764–774.CrossRefPubMed
2.
go back to reference van Delden, C. 2007. Pseudomonas aeruginosa bloodstream infections: how should we treat them? Int J Antimicrob Agents 30(Suppl 1): S71–75.CrossRefPubMed van Delden, C. 2007. Pseudomonas aeruginosa bloodstream infections: how should we treat them? Int J Antimicrob Agents 30(Suppl 1): S71–75.CrossRefPubMed
3.
go back to reference Bassetti, M., G. Villa, and D. Pecori. 2014. Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation. Future Microbiol 9: 465–474.CrossRefPubMed Bassetti, M., G. Villa, and D. Pecori. 2014. Antibiotic-resistant Pseudomonas aeruginosa: focus on care in patients receiving assisted ventilation. Future Microbiol 9: 465–474.CrossRefPubMed
4.
go back to reference Tumbarello, M., E. Repetto, E.M. Trecarichi, C. Bernardini, G. De Pascale, et al. 2011. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Epidemiol Infect 139: 1740–1749.CrossRefPubMed Tumbarello, M., E. Repetto, E.M. Trecarichi, C. Bernardini, G. De Pascale, et al. 2011. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Epidemiol Infect 139: 1740–1749.CrossRefPubMed
5.
go back to reference Duszynska, W. 2012. Strategies of empiric antibiotic therapy in severe sepsis. Anaesthesiol Intensive Ther 44: 96–103.PubMed Duszynska, W. 2012. Strategies of empiric antibiotic therapy in severe sepsis. Anaesthesiol Intensive Ther 44: 96–103.PubMed
6.
go back to reference Carrigan, S.O., R. Junkins, Y.J. Yang, A. Macneil, C. Richardson, et al. 2010. IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice. J Immunol 185: 3602–3609.CrossRefPubMed Carrigan, S.O., R. Junkins, Y.J. Yang, A. Macneil, C. Richardson, et al. 2010. IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice. J Immunol 185: 3602–3609.CrossRefPubMed
7.
8.
go back to reference Bordon, J., S. Aliberti, R. Fernandez-Botran, S.M. Uriarte, M.J. Rane, et al. 2013. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis 17: e76–83.CrossRefPubMed Bordon, J., S. Aliberti, R. Fernandez-Botran, S.M. Uriarte, M.J. Rane, et al. 2013. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis 17: e76–83.CrossRefPubMed
9.
go back to reference Gellatly, S.L., and R.E. Hancock. 2013. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis 67: 159–173.CrossRefPubMed Gellatly, S.L., and R.E. Hancock. 2013. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis 67: 159–173.CrossRefPubMed
10.
go back to reference Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6: 644–658.CrossRefPubMed Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6: 644–658.CrossRefPubMed
11.
go back to reference O’Connell, R.M., S.K. Saha, S.A. Vaidya, K.W. Bruhn, G.A. Miranda, et al. 2004. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med 200: 437–445.CrossRefPubMedPubMedCentral O’Connell, R.M., S.K. Saha, S.A. Vaidya, K.W. Bruhn, G.A. Miranda, et al. 2004. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med 200: 437–445.CrossRefPubMedPubMedCentral
12.
go back to reference Stockinger, S., B. Reutterer, B. Schaljo, C. Schellack, S. Brunner, et al. 2004. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism. J Immunol 173: 7416–7425.CrossRefPubMed Stockinger, S., B. Reutterer, B. Schaljo, C. Schellack, S. Brunner, et al. 2004. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism. J Immunol 173: 7416–7425.CrossRefPubMed
13.
go back to reference Opitz, B., M. Vinzing, V. van Laak, B. Schmeck, G. Heine, et al. 2006. Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J Biol Chem 281: 36173–36179.CrossRefPubMed Opitz, B., M. Vinzing, V. van Laak, B. Schmeck, G. Heine, et al. 2006. Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J Biol Chem 281: 36173–36179.CrossRefPubMed
14.
go back to reference Buss, C., B. Opitz, A.C. Hocke, J. Lippmann, V. van Laak, et al. 2010. Essential role of mitochondrial antiviral signaling, IFN regulatory factor (IRF)3, and IRF7 in Chlamydophila pneumoniae-mediated IFN-beta response and control of bacterial replication in human endothelial cells. J Immunol 184: 3072–3078.CrossRefPubMed Buss, C., B. Opitz, A.C. Hocke, J. Lippmann, V. van Laak, et al. 2010. Essential role of mitochondrial antiviral signaling, IFN regulatory factor (IRF)3, and IRF7 in Chlamydophila pneumoniae-mediated IFN-beta response and control of bacterial replication in human endothelial cells. J Immunol 184: 3072–3078.CrossRefPubMed
15.
go back to reference Walker, W.E., A.T. Bozzi, and D.R. Goldstein. 2012. IRF3 contributes to sepsis pathogenesis in the mouse cecal ligation and puncture model. J Leukoc Biol 92: 1261–1268.CrossRefPubMedPubMedCentral Walker, W.E., A.T. Bozzi, and D.R. Goldstein. 2012. IRF3 contributes to sepsis pathogenesis in the mouse cecal ligation and puncture model. J Leukoc Biol 92: 1261–1268.CrossRefPubMedPubMedCentral
16.
go back to reference Fischer, H., N. Lutay, B. Ragnarsdottir, M. Yadav, K. Jonsson, et al. 2010. Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. PLoS Pathog 6: e1001109.CrossRefPubMedPubMedCentral Fischer, H., N. Lutay, B. Ragnarsdottir, M. Yadav, K. Jonsson, et al. 2010. Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. PLoS Pathog 6: e1001109.CrossRefPubMedPubMedCentral
17.
go back to reference Sakaguchi, S., H. Negishi, M. Asagiri, C. Nakajima, T. Mizutani, et al. 2003. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun 306: 860–866.CrossRefPubMed Sakaguchi, S., H. Negishi, M. Asagiri, C. Nakajima, T. Mizutani, et al. 2003. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun 306: 860–866.CrossRefPubMed
18.
go back to reference Moore, T.C., L. Cody, P.M. Kumm, D.M. Brown, and T.M. Petro. 2013. IRF3 helps control acute TMEV infection through IL-6 expression but contributes to acute hippocampus damage following TMEV infection. Virus Res 178: 226–233.CrossRefPubMed Moore, T.C., L. Cody, P.M. Kumm, D.M. Brown, and T.M. Petro. 2013. IRF3 helps control acute TMEV infection through IL-6 expression but contributes to acute hippocampus damage following TMEV infection. Virus Res 178: 226–233.CrossRefPubMed
19.
go back to reference Chung, J.W., Z.H. Piao, S.R. Yoon, M.S. Kim, M. Jeong, et al. 2009. Pseudomonas aeruginosa eliminates natural killer cells via phagocytosis-induced apoptosis. PLoS Pathog 5: e1000561.CrossRefPubMedPubMedCentral Chung, J.W., Z.H. Piao, S.R. Yoon, M.S. Kim, M. Jeong, et al. 2009. Pseudomonas aeruginosa eliminates natural killer cells via phagocytosis-induced apoptosis. PLoS Pathog 5: e1000561.CrossRefPubMedPubMedCentral
20.
go back to reference Lovewell, R.R., Y.R. Patankar, and B. Berwin. 2014. Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 306: L591–603.CrossRefPubMedPubMedCentral Lovewell, R.R., Y.R. Patankar, and B. Berwin. 2014. Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 306: L591–603.CrossRefPubMedPubMedCentral
22.
go back to reference Prince, L.R., S.M. Bianchi, K.M. Vaughan, M.A. Bewley, H.M. Marriott, et al. 2008. Subversion of a lysosomal pathway regulating neutrophil apoptosis by a major bacterial toxin, pyocyanin. J Immunol 180: 3502–3511.CrossRefPubMedPubMedCentral Prince, L.R., S.M. Bianchi, K.M. Vaughan, M.A. Bewley, H.M. Marriott, et al. 2008. Subversion of a lysosomal pathway regulating neutrophil apoptosis by a major bacterial toxin, pyocyanin. J Immunol 180: 3502–3511.CrossRefPubMedPubMedCentral
23.
go back to reference Allen, L., D.H. Dockrell, T. Pattery, D.G. Lee, P. Cornelis, et al. 2005. Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo. J Immunol 174: 3643–3649.CrossRefPubMed Allen, L., D.H. Dockrell, T. Pattery, D.G. Lee, P. Cornelis, et al. 2005. Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo. J Immunol 174: 3643–3649.CrossRefPubMed
24.
go back to reference Chattopadhyay, S., J.T. Marques, M. Yamashita, K.L. Peters, K. Smith, et al. 2010. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J 29: 1762–1773.CrossRefPubMedPubMedCentral Chattopadhyay, S., J.T. Marques, M. Yamashita, K.L. Peters, K. Smith, et al. 2010. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J 29: 1762–1773.CrossRefPubMedPubMedCentral
25.
go back to reference Iwai, A., T. Shiozaki, and T. Miyazaki. 2013. Relevance of signaling molecules for apoptosis induction on influenza A virus replication. Biochem Biophys Res Commun 441: 531–537.CrossRefPubMed Iwai, A., T. Shiozaki, and T. Miyazaki. 2013. Relevance of signaling molecules for apoptosis induction on influenza A virus replication. Biochem Biophys Res Commun 441: 531–537.CrossRefPubMed
26.
go back to reference Ramirez-Estrada, S., B. Borgatta, and J. Rello. 2016. Pseudomonas aeruginosa ventilator-associated pneumonia management. Infect Drug Resist 9: 7–18.PubMedPubMedCentral Ramirez-Estrada, S., B. Borgatta, and J. Rello. 2016. Pseudomonas aeruginosa ventilator-associated pneumonia management. Infect Drug Resist 9: 7–18.PubMedPubMedCentral
27.
go back to reference Kolaczkowska, E., and P. Kubes. 2013. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13: 159–175.CrossRefPubMed Kolaczkowska, E., and P. Kubes. 2013. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13: 159–175.CrossRefPubMed
28.
29.
go back to reference Kim, H.Y., E.A. Skokos, D.J. Myer, P. Agaba, and A.L. Gonzalez. 2014. alphaVbeta3 Integrin Regulation of Respiratory Burst in Fibrinogen Adherent Human Neutrophils. Cell Mol Bioeng 7: 231–242.CrossRefPubMedPubMedCentral Kim, H.Y., E.A. Skokos, D.J. Myer, P. Agaba, and A.L. Gonzalez. 2014. alphaVbeta3 Integrin Regulation of Respiratory Burst in Fibrinogen Adherent Human Neutrophils. Cell Mol Bioeng 7: 231–242.CrossRefPubMedPubMedCentral
30.
go back to reference Sarangi, P.P., Y.M. Hyun, Y.V. Lerman, A.P. Pietropaoli, and M. Kim. 2012. Role of beta1 integrin in tissue homing of neutrophils during sepsis. Shock 38: 281–287.CrossRefPubMedPubMedCentral Sarangi, P.P., Y.M. Hyun, Y.V. Lerman, A.P. Pietropaoli, and M. Kim. 2012. Role of beta1 integrin in tissue homing of neutrophils during sepsis. Shock 38: 281–287.CrossRefPubMedPubMedCentral
31.
go back to reference Harris, E.S., T.M. McIntyre, S.M. Prescott, and G.A. Zimmerman. 2000. The leukocyte integrins. J Biol Chem 275: 23409–23412.CrossRefPubMed Harris, E.S., T.M. McIntyre, S.M. Prescott, and G.A. Zimmerman. 2000. The leukocyte integrins. J Biol Chem 275: 23409–23412.CrossRefPubMed
34.
go back to reference Evans, R., I. Patzak, L. Svensson, K. De Filippo, K. Jones, et al. 2009. Integrins in immunity. J Cell Sci 122: 215–225.CrossRefPubMed Evans, R., I. Patzak, L. Svensson, K. De Filippo, K. Jones, et al. 2009. Integrins in immunity. J Cell Sci 122: 215–225.CrossRefPubMed
35.
go back to reference Manago, A., K.A. Becker, A. Carpinteiro, B. Wilker, M. Soddemann, et al. 2015. Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase. Antioxid Redox Signal 22: 1097–1110.CrossRefPubMedPubMedCentral Manago, A., K.A. Becker, A. Carpinteiro, B. Wilker, M. Soddemann, et al. 2015. Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase. Antioxid Redox Signal 22: 1097–1110.CrossRefPubMedPubMedCentral
36.
go back to reference Usher, L.R., R.A. Lawson, I. Geary, C.J. Taylor, C.D. Bingle, et al. 2002. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol 168: 1861–1868.CrossRefPubMed Usher, L.R., R.A. Lawson, I. Geary, C.J. Taylor, C.D. Bingle, et al. 2002. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol 168: 1861–1868.CrossRefPubMed
Metadata
Title
IRF3 Inhibits Neutrophil Recruitment in Mice Infected with Pseudomonas aeruginosa
Authors
Zhenghao Piao
Haiying Yuan
Cuili Wang
Liyun Shi
Publication date
01-06-2017
Publisher
Springer US
Published in
Inflammation / Issue 3/2017
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0517-5

Other articles of this Issue 3/2017

Inflammation 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.